CGENCompugen Ltd.

$215M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$8M

Net Income

-$8M

EPS (Diluted)

$-0.09

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

$0

Free Cash Flow

$0

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$143M

Total Liabilities

$16M

Stockholders' Equity

$127M

Cash & Equivalents

$133M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$8M	-$7M	-23.4%
Net Income	-$8M	-$6M	-19.6%

CGEN Q3 2020 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena